Donate to support our work
Global Asthma Network Logo Global Asthma Network Global Asthma Network Logo
  • The Global Asthma Network strives for a world where no-one suffers from asthma

  • The Global Asthma Network is the asthma surveillance hub for the world

  • The Global Asthma Network researches ways of reducing the burden of asthma

  • The Global Asthma Network promotes access to appropriate asthma management

  • The Global Asthma Network stimulates and encourages capacity building in LMICs

  • The Global Asthma Network strives to ensure access to quality-assured essential asthma medications

  • The Global Asthma Network raises the profile of asthma as a major NCD

Respiratory and Allergy Organisations


The Global Alliance against Chronic Respiratory Diseases (GARD) is a voluntary alliance of national and international organizations, institutions, and agencies commited towards the common goal to reduce the global burden of respiratory diseases.

GARD Newsletter June 2019

GARD Action Plan 2008-2013

GARD basket: A package of information, surveillance tools and guidelines


The Global Initiative for Asthma (GINA) works with health care professionals and public health officials around the world to reduce asthma prevalence, morbidity, and mortality. Through resources such as evidence-based strategies for asthma management, projects such as the Asthma Control Challenge to reduce hospitalizations, and events such as the annual celebration of World Asthma Day, GINA is working to improve the lives of people with asthma in every corner of the globe.

FIRS (Forum of International Respiratory Societies)

The Forum of International Respiratory Societies (FIRS) was established in 2002, with members coming from leading international professional respiratory societies (listed below). The forum aims to promote advocacy in matters of global respiratory health and the identification of new areas for global initiatives. FIRS has collaborations with the Global Alliance against Chronic Respiratory Diseases (GARD), the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and the Global Initiative for Asthma (GINA). It organised the “Year of the Lung” (2010) and World Spirometry Day in 2012 and is planning another for 2014.

FIRS Documents

Electronic Cigarettes: A position statement of the Forum of International Respiratory Societies

Respiratory diseases in the world. Realities of Today – Opportunities for Tomorrow

Forum of International Respiratory Societies (FIRS) advocacy statement

FIRS Member Organisations


The American Academy of Allergy, Asthma & Immunology (AAAAI) is a professional organization with more than 6,700 members in the United States, Canada and 72 other countries. This membership includes allergist / immunologists, other medical specialists, allied health and related healthcare professionals—all with a special interest in the research and treatment of allergic and immunologic diseases. The American Academy of Allergy, Asthma & Immunology is dedicated to the advancement of the knowledge and practice of allergy, asthma and immunology for optimal patient care.


The American College of Allergy, Asthma & Immunology (ACAAI), established in 1942, is a professional association of more than 5,700 allergists/immunologists and allied health professionals. Its mission is to promote excellence in the practice of the subspecialty of allergy and immunology. The College fosters a culture of collaboration and congeniality in which its members work together and with others toward the common goals of patient care, education, advocacy and research.


Founded in 1935, the American College of Chest Physicians (ACCP) has more than 18,700 members in over 100 countries. Members include clinicians in private practice, academia, and industry who specialize in a myriad of chest-related disciplines, including asthma, COPD, sleep disorders, pulmonary hypertension, lung cancer, thrombosis, critical and palliative care, chest infections, pediatric chest medicine, and more. The ACCP has recently strengthened its global efforts through partnerships and key initiatives with medical organizations in India, China, and Greece. The ACCP annual CHEST meeting is recognized as the world’s largest clinical chest medicine event, providing attendees with the latest research and essential updates on patient care and practice management strategies.


La Asociación Latino Americana de Tórax (ALAT) es una asociación sin fines de lucro, internacional, profesional y científica dirigida a las enfermedades respiratorias. Es una asociación comprometida con la prevención y el tratamiento de las enfermedades respiratorias a través de la investigación, de la educación, de los cuidados y de la defensa de los pacientes. Tiene como objetivo coordinar y trabajar recíprocamente con otras organizaciones nacionales e internacionales que tengan los mismos fines, con el propósito de disminuir la morbilidad y la mortalidad secundarios a las enfermedades respiratorias en personas de todas las edades.

The Latin American Association of Thorax (Asociación Latino Americana de Tórax, ALAT) is a non-profit, professional and scientific association focused on respiratory diseases. It is an association engaged to prevent and treat respiratory diseases through research, education, care and defence of patients. Its objective is to coordinate and work reciprocally with other national and international organizations which share similar aims, with the purpose of diminishing morbidity and mortality from respiratory diseases in persons of all ages.


The Asia Pacific Society of Respirology (APSR) was established in 1986. The objectives of the Society are the advancement and promotion of knowledge of the respiratory system in health and disease. It strives to encourage research, improve clinical practice through teaching, increase awareness of health problems in the area and promote the exchange of knowledge among respirologists in the Asia Pacific region.


The American Thoracic Society (ATS) improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, the ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases. It also runs the highly regarded annual ATS International Conference.


The European Academy of Allergy and Clinical Immunology (EAACI) is an association of clinicians, researchers and allied health professionals, dedicated to improving the health of people affected by allergic diseases. With over 7,400 members from 121 countries and 42 National Societies, EAACI is the primary source of expertise in Europe for all aspects of allergy.

The main event of EAACI is its annual four or five day Congress. EAACI also organizes Focused Meetings on specific topics, Allergy Schools in summer and winter and other scientific symposia.



The European Respiratory Society (ERS) is the leading professional organisation in its field in Europe. It is broad-based, with some 10,000 members and counting in over 100 countries. Its scope covers both basic science and clinical medicine. ERS seeks to alleviate suffering from respiratory disease and promote lung health through research, sharing of knowledge and through medical and public education.

The main event of the ERS is the ERS Annual Congress.

European Respiratory Monograph

The ERS has recently published the Paediatric Asthma issue of its quarterly book series, the European Respiratory Monograph (ERM). The issue is Guest Edited by leaders in the field Professor Kai-Håkon Carlsen and Professor Jorrit Gerritsen, who have brought together distinguished pulmonologists to provide a comprehensive review of paediatric asthma. All aspects of paediatric asthma are covered, from birth to the start of adulthood, and the issue includes chapters on: asthma phenotypes; physical exercise; food allergy and anaphylaxis; genetics and epigenetics; pollution; asthma treatment; and psychological factors. This issue of the ERM book series should prove a useful resource in daily clinical practice, and it is hoped that young pulmonologists in particular will find this a source of inspiration in their future work.

ERS members can freely access the Paediatric Asthma issue online at To purchase a print copy of the issue or to find out more about the ERM, contact


The International Collaboration in Asthma, Allergy and Immunology (iCAALL) is a collaboration between the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma & Immunology (ACAAI), the European Academy of Allergy and Clinical Immunology (EAACI) and the World Allergy Organization (WAO).

iCAALL is designed to collect and disseminate consensus-driven information about allergies, asthma and immunological diseases. Communicating this knowledge can positively impact diagnosis and treatment, as well as cost containment and policy decisions.

A major focus of this initiative is the production of a series of International Consensus (ICON) reports. These documents offer general recommendations based on global challenges in caring for patients with allergic and immunologic diseases. A Food Allergy ICON was published in April, 2012. An ICON on Pediatric Asthma was published in June, 2012.


The International Multidisciplinary Programme to Address Lung Health and TB in Africa (IMPALA) is a four-year collaborative programme funded by the National Institute of Health Research under the first Global Health Research Programme call launched in 2016.

LSTM was successful in securing funding under this call to establish an Africa-focused NIHR Global Health Research Unit for lung health and tuberculosis (TB) that will generate new scientific knowledge and implementable solutions for these high burden, under-funded and under-researched health problems. Read more...

Download Factsheet


The International Study of Asthma and Allergies in Childhood (ISAAC) is the largest collaborative epidemiological study of children in the world. ISAAC has measured the symptom prevalence of asthma, rhinitis and eczema in almost 2 million children in 105 countries. The ISAAC findings have demonstrated that asthma and allergies are a global health problem and environmental factors are key. The ISAAC methodology and surveillance tools have been adopted by the epidemiological community and are widely used in studies of asthma, rhinitis and eczema throughout the world.


The ISAAC Story

A complete history of ISAAC, The International Study of Asthma and Allergies in Childhood, including its tools and methodologies. This unique worldwide epidemiological research programme established in 1991 to investigate asthma, rhinitis and eczema in children became the largest worldwide collaborative research project ever undertaken, involving more than 100 countries and nearly 2 million children. ISAAC findings are cited by any organization involved in monitoring and preventing chronic respiratory diseases and are used to inform global health initiatives which include WHO, and its NGO the Global Alliance against Chronic Respiratory Diseases (GARD).

ISAAC Symposium 2011

Presentations from The ISAAC 20 year Anniversary Symposium held in Auckland, New Zealand in January 2011, on recent research and findings in the fields of asthma, eczema, and rhinitis, available to download.


The Pan African Thoracic Society (PATS) has been created to provide a new impetus to respiratory medicine in Africa. It aims to inform African resolutions for African problems and provide solutions to suit specific situations.

Africa is the continent most afflicted by morbidity and death from respiratory disease. As well as the burden of pneumonia and HIV-related respiratory illness including TB, there is an increasing problem with asthma and tobacco related disease. Biomass fuel use is ubiquitous and likely to be a major contributor to the prevalence of both pulmonary infection and COPD. Children under 15 years make up almost 50% of the population in African countries; childhood respiratory illness is the major cause of pediatric morbidity, health care utilization and mortality in Africa.

The role of PATS is to try and unite all interested groups and individuals across the continent toward finding appropriate solutions to these challenges. PATS role must be to inform, to sensitise, and to educate.

The Union

The mission of the International Union Against Tuberculosis and Lung Disease (The Union) is to bring innovation, expertise, solutions and support to address health challenges in low- and middle-income populations. With close to 3,000 organisations and individuals who are committed to the same goals, The Union has its headquarters in Paris and offices serving the Africa, Asia Pacific, Europe, Latin America, Middle East, North America and South-East Asia regions. Its scientific departments focus on tuberculosis, HIV, lung health and non-communicable diseases, tobacco control and research.



The World Allergy Organization (WAO) is an international umbrella organization whose members consist of 92 regional and national allergology and clinical immunology societies from around the world. By collaborating with member societies, WAO provides direct educational outreach programs, symposia and lectureships to members in nearly 100 countries around the globe.

Other Respiratory Organisations


The Thoracic Society of Australia and New Zealand (TSANZ) is a company limited by guarantee established to improve the knowledge and understanding of lung disease, to prevent respiratory illness through research and health promotion, and improving health care for people with respiratory disorders.

To achieve these aims, the Society promotes the:

  • highest quality and standards of patient care
  • development and application of knowledge about respiration and respiratory disease
  • collaboration between all national organisations whose objects are to improve the well being of individuals with lung disease and to promote better lung health for the community
  • professional needs of the membership
  • goal of a tobacco smoke free society.


The Australasian Society of Clinical Immunology and Allergy (ASCIA) is a professional medical organisation, comprised predominantly of clinical immunology and allergy medical specialists. The ASCIA membership also includes other medical practioners, scientists and allied health professionals (mainly nurses and dietitians) who work in the areas of allergy and immunology.

ASCIA is a member society of the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) and the World Allergy Organisation (WAO).